info@seagull-health.com
SeagullHealth
语言:
search

Camzyos(mavacamten) Side Effects

The most common adverse reactions to CAMZYOS are dizziness and syncope, with heart failure as a serious risk.

Adverse Reactions and Safety Profile of CAMZYOS

The safety profile of CAMZYOS is characterized by a higher incidence of dizziness (27%) and syncope (6%) compared to placebo. Heart failure due to systolic dysfunction is a significant risk, necessitating prompt interruption of therapy if LVEF falls below 50% or if symptoms worsen. Other adverse effects include hypotension and, rarely, asystole in overdose scenarios. CAMZYOS may also interact with other drugs, leading to increased or decreased efficacy or toxicity. Adverse effects in pediatric, pregnant, or lactating patients are not specified in the description.

Mavacamten(Camzyos)
Mavacamten(Camzyos)
CAMZYOS (mavacamten) is specifically indicated for the treatment of adult...
WeChat Scan
Free Inquiry
Related articles
Mavacamten (Camzyos) Side Effect Management and Storage Guidelines
Mavacamten (Camzyos) is used for the treatment of obstructive hypertrophic cardiomyopathy with significant efficacy, but side effects may occur during administration.I. Common Side Effects1. Dizziness...
Side Effects of Mavacamten (Camzyos)
Mavacamten (Camzyos) is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM), New York Heart Association (NYHA) functional cl...
Adverse Effects of Mavacamten (Camzyos)
Mavacamten (Camzyos) is a cardiac myosin inhibitor indicated for the treatment of adult patients with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy...
Side Effects of Mavacamten (Camzyos)
Mavacamten (Camzyos) is a medication indicated for the treatment of adult patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). As a drug with a unique mechanism of action, mavacamt...
What are the common side effects of Mavacamten capsule?
Mavacamten capsule is a drug for the treatment of obstructive hypertrophic cardiomyopathy. It improves heart function, relieves symptoms and improves the quality of life of patients by reducing t...
共 5 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved